Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
14 Fevereiro 2025 - 6:33PM
Edgar (US Regulatory)
EXHIBIT 1
JOINT FILING AGREEMENT
The undersigned hereby agree that the statement on Schedule
13G with respect to the Voting Common Stock of TScan Therapeutics, Inc., dated as of February 14, 2025, is, and any amendments thereto (including amendments on Schedule 13D) signed by each of the undersigned shall be, filed on behalf of each
of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
|
Dated: February 14, 2025
|
|
|
|
|
|
|
K2 HEALTHVENTURES EQUITY TRUST LLC
|
|
|
|
|
|
|
By:
|
/s/ Anup Arora
|
|
|
Name:
|
Anup Arora
|
|
|
Title:
|
Managing Member
|
|
|
|
|
|
PARAG SHAH
|
|
|
|
|
|
By:
|
/s/ Parag Shah
|
|
|
|
|
|
ANUP ARORA
|
|
|
By:
|
/s/ Anup Arora
|
TScan Therapeutics (NASDAQ:TCRX)
Gráfico Histórico do Ativo
De Fev 2025 até Mar 2025
TScan Therapeutics (NASDAQ:TCRX)
Gráfico Histórico do Ativo
De Mar 2024 até Mar 2025
